AACR Gertrude B. Elion Cancer Research Award
This award supports tenure-eligible junior faculty worldwide in conducting innovative basic, translational, or clinical cancer research to advance understanding or treatment of cancer.
Funder: American Association for Cancer Research
Due Dates: June 4, 2026 (Letter of Intent) | September 16, 2026 (Full application, invited only)
Funding Amounts: $225,000 for a one-year project; supports research-related costs including salary, staff, supplies, equipment, travel, and publication fees.
Summary: Supports tenure-eligible junior faculty worldwide conducting innovative research on cancer etiology, diagnosis, treatment, or prevention.
Key Information: AACR membership in good standing is required by the LOI deadline; only assistant professors (tenure-eligible) within 6 years of first faculty appointment are eligible.
Description
This award, supported by GlaxoSmithKline and administered by the American Association for Cancer Research (AACR), aims to encourage and support tenure-eligible junior faculty whose research addresses cancer etiology, diagnosis, treatment, or prevention. The grant funds basic, translational, or clinical research projects and covers a broad range of research-related expenses. The program is highly competitive and requires a two-stage application process, beginning with a Letter of Intent (LOI).
